ESMO26: Toni Choueiri, MD on LITESPARK-012 | Dana-Farber Cancer Institute
RCC Content Hub
Surprising results in first triplet combination study in advanced kidney cancer presented by Toni Choueiri, MD, at #ESMO26. Dr. Choueiri says even though the combination did not improve efficacy, the findings are important for informing future studies.
Video published Oct 30, 2026